Journal
BIOMARKERS
Volume 13, Issue 1, Pages 106-118Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/13547500701673529
Keywords
arylamine N-acetyltransferase/NAT; adrenal; embryo; breast cancer
Categories
Funding
- NATIONAL CANCER INSTITUTE [R01CA034627] Funding Source: NIH RePORTER
- NCI NIH HHS [CA-34627, R01 CA034627, R01 CA034627-22] Funding Source: Medline
- Wellcome Trust Funding Source: Medline
Ask authors/readers for more resources
Arylamine N-acetyltransferase (NAT) genes in humans and in rodents encode polymorphic drug metabolizing enzymes. Human NAT1 (and the murine equivalent mouse Nat2) is found early in embryonic development and is likely to have an endogenous role. We report the detailed expression of the murine gene (Nat2) and encoded protein in mouse embryos, using a transgenic mouse model bearing a lacZ transgene inserted into the coding region of mouse Nat2. In mouse embryos, the transgene was expressed in sensory epithelia, epithelial placodes giving rise to visceral sensory neurons, the developing pituitary gland, sympathetic chain and urogenital ridge. In Nat2(+/+) mice, the presence and activity of Nat2 protein was detected in these tissues and their adult counterparts. Altered expression of the human orthologue in breast tumours, in which there is endocrine signalling, suggests that human NAT1 should be considered as a potential biomarker for neuroendocrine tissues and tumours.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available